These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 8293464)

  • 1. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.
    Germain RN
    Cell; 1994 Jan; 76(2):287-99. PubMed ID: 8293464
    [No Abstract]   [Full Text] [Related]  

  • 2. MHC class II-restricted antigen processing and presentation.
    Pieters J
    Adv Immunol; 2000; 75():159-208. PubMed ID: 10879284
    [No Abstract]   [Full Text] [Related]  

  • 3. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways.
    Teyton L; O'Sullivan D; Dickson PW; Lotteau V; Sette A; Fink P; Peterson PA
    Nature; 1990 Nov; 348(6296):39-44. PubMed ID: 2234057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation.
    Gregers TF; Fleckenstein B; Vartdal F; Roepstorff P; Bakke O; Sandlie I
    Int Immunol; 2003 Nov; 15(11):1291-9. PubMed ID: 14565927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen presentation: structural themes and functional variations.
    Braciale TJ; Braciale VL
    Immunol Today; 1991 Apr; 12(4):124-9. PubMed ID: 1711855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cell biology of antigen processing.
    Levine TP; Chain BM
    Crit Rev Biochem Mol Biol; 1991; 26(5-6):439-73. PubMed ID: 1722142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptides bound to major histocompatibility complex molecules.
    Maffei A; Harris PE
    Peptides; 1998; 19(1):179-98. PubMed ID: 9437752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
    Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
    Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endosomal compartment: Also a dock for MHC class I peptide loading.
    Ma W; Van den Eynde BJ
    Eur J Immunol; 2014 Mar; 44(3):650-3. PubMed ID: 24515851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathway of antigen uptake and processing dictates MHC class II-mediated B cell survival and activation.
    Nashar TO; Drake JR
    J Immunol; 2005 Feb; 174(3):1306-16. PubMed ID: 15661887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of T cells by antigen-presenting cells is kinetically controlled by antigenic peptide binding to major histocompatibility complex class II molecules.
    McConnell HM; Wada HG; Arimilli S; Fok KS; Nag B
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2750-4. PubMed ID: 7708718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L; Ullrich SJ; Appella E; Fuchs S
    Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation of subcellular compartments containing distinct functional forms of MHC class II.
    Qiu Y; Xu X; Wandinger-Ness A; Dalke DP; Pierce SK
    J Cell Biol; 1994 May; 125(3):595-605. PubMed ID: 7909813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen presenting cells.
    Hamilos DL
    Immunol Res; 1989; 8(2):98-117. PubMed ID: 2659691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative responses to allogeneic HLA class I peptides.
    Paraoan MT; Sells RA; Bakran A; Hammad A; Christmas SE
    Transplant Proc; 2001; 33(1-2):334-5. PubMed ID: 11266848
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biochemistry and cell biology of antigen presentation by MHC class I and class II molecules. Implications for development of combination vaccines.
    Germain RN
    Ann N Y Acad Sci; 1995 May; 754():114-25. PubMed ID: 7625645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The recognition of MHC molecules by gamma delta T cells.
    Schild H; Chien YH
    Behring Inst Mitt; 1994 Jul; (94):113-23. PubMed ID: 7998905
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 33.